Smith Chas P & Associates PA Cpas trimmed its position in The Clorox Company (NYSE:CLX – Free Report) by 18.1% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,550 shares of the company’s stock after selling 343 shares during the quarter. Smith Chas P & Associates PA Cpas’ holdings in Clorox were worth $252,000 at the end of the most recent quarter.
Other institutional investors have also made changes to their positions in the company. Brooklyn Investment Group boosted its position in Clorox by 163.8% during the 4th quarter. Brooklyn Investment Group now owns 153 shares of the company’s stock worth $25,000 after acquiring an additional 95 shares during the period. Prospera Private Wealth LLC acquired a new stake in shares of Clorox during the third quarter worth approximately $27,000. Continuum Advisory LLC grew its position in Clorox by 300.0% during the third quarter. Continuum Advisory LLC now owns 184 shares of the company’s stock valued at $30,000 after purchasing an additional 138 shares in the last quarter. Quarry LP increased its stake in Clorox by 99.1% in the 2nd quarter. Quarry LP now owns 229 shares of the company’s stock valued at $31,000 after buying an additional 114 shares during the period. Finally, Carolina Wealth Advisors LLC purchased a new stake in Clorox in the 3rd quarter worth approximately $48,000. 78.53% of the stock is owned by hedge funds and other institutional investors.
Wall Street Analyst Weigh In
A number of equities analysts have recently weighed in on the stock. DA Davidson upped their price target on shares of Clorox from $153.00 to $171.00 and gave the stock a “neutral” rating in a research note on Monday, November 4th. Barclays dropped their target price on Clorox from $139.00 to $130.00 and set an “underweight” rating on the stock in a research report on Friday, January 17th. Evercore ISI reduced their price target on Clorox from $140.00 to $139.00 and set an “underperform” rating for the company in a report on Monday, October 14th. Jefferies Financial Group upgraded Clorox from a “hold” rating to a “buy” rating and increased their price objective for the stock from $174.00 to $187.00 in a report on Tuesday, October 1st. Finally, Wells Fargo & Company upgraded shares of Clorox from an “underweight” rating to an “equal weight” rating and lifted their target price for the company from $155.00 to $157.00 in a research note on Tuesday, January 7th. Four investment analysts have rated the stock with a sell rating, ten have assigned a hold rating and one has assigned a buy rating to the stock. According to data from MarketBeat, the stock has an average rating of “Hold” and a consensus price target of $156.54.
Clorox Stock Performance
Shares of NYSE CLX opened at $159.12 on Friday. The Clorox Company has a one year low of $127.60 and a one year high of $171.37. The company has a current ratio of 1.00, a quick ratio of 0.62 and a debt-to-equity ratio of 11.08. The business has a fifty day simple moving average of $163.66 and a 200 day simple moving average of $157.32. The firm has a market capitalization of $19.70 billion, a price-to-earnings ratio of 55.44, a PEG ratio of 2.92 and a beta of 0.42.
Clorox (NYSE:CLX – Get Free Report) last issued its earnings results on Wednesday, October 30th. The company reported $1.86 earnings per share for the quarter, beating the consensus estimate of $1.36 by $0.50. Clorox had a net margin of 4.78% and a return on equity of 316.08%. The business had revenue of $1.76 billion for the quarter, compared to analyst estimates of $1.64 billion. During the same period in the previous year, the business earned $0.49 EPS. The firm’s revenue was up 27.0% on a year-over-year basis. Sell-side analysts expect that The Clorox Company will post 6.87 EPS for the current year.
Clorox Dividend Announcement
The business also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Wednesday, January 29th will be given a dividend of $1.22 per share. The ex-dividend date of this dividend is Wednesday, January 29th. This represents a $4.88 annualized dividend and a dividend yield of 3.07%. Clorox’s dividend payout ratio (DPR) is presently 170.04%.
About Clorox
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
Featured Stories
- Five stocks we like better than Clorox
- 3 Ways To Invest In Coffee, Other Than Drinking It
- Bloom Energy: Powering the Future With Decentralized Energy
- Want to Profit on the Downtrend? Downtrends, Explained.
- Dividend Powerhouses: Blue-Chip Stocks Built for the Long Haul
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- Why Traders Are Buying the Dip on Johnson & Johnson Stock
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX – Free Report).
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.